As of Oct 20
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 3.10, with a high estimate of 7.30 and a low estimate of 2.00. The median estimate represents a +210.00% increase from the last price of 1.00.
The current consensus among 3 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.